(Q42572770)

2 November 2017

Declining Guillain-Barré syndrome after campylobacteriosis control, New Zealand, 1988-2010. (English)

1 reference

2 November 2017

Guillain–Barré syndrome

0 references

0 references

0 references

1

Michael G Baker

1 reference

2 November 2017

2

Amanda Kvalsvig

1 reference

2 November 2017

6

Nick Wilson

1 reference

2 November 2017

Jane Zhang

3

1 reference

2 November 2017

Rob Lake

series ordinal

4

1 reference

2 November 2017

Ann Sears

series ordinal

5

1 reference

2 November 2017

1 February 2012

1 reference

Emerging Infectious Diseases

2 November 2017

1 reference

2 November 2017

18

1 reference

2 November 2017

2

1 reference

2 November 2017

226-233

1 reference

Marked campylobacteriosis decline after interventions aimed at poultry, New Zealand

2 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3310455

Longitudinal study of infectious intestinal disease in the UK (IID2 study): incidence in the community and presenting to general practice

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3310455

Population Incidence of Guillain-Barré Syndrome: A Systematic Review and Meta-Analysis

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3310455

Quantifying the association between Campylobacter infection and Guillain-Barré syndrome: a systematic review

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3310455

Guillain-Barré syndrome after exposure to influenza virus

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3310455

A surveillance sector review applied to infectious diseases at a country level

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3310455

Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3310455

The epidemiology of Guillain-Barré syndrome worldwide. A systematic literature review

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3310455

Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3310455

Estimating community incidence of Salmonella, Campylobacter, and Shiga toxin-producing Escherichia coli infections, Australia

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3310455

Guillain-Barré syndrome: incidence and mortality rates in US hospitals

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3310455

Guillain-Barré syndrome after transplantation

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3310455

Guillain-Barré syndrome and preceding infection with campylobacter, influenza and Epstein-Barr virus in the general practice research database.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3310455

Immunotherapy for Guillain-Barre syndrome: a systematic review

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3310455

Is the major increase in notified campylobacteriosis in New Zealand real?

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3310455

Lymphoma and peripheral neuropathy: a clinical review

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3310455

Lack of association between long-term illness and infectious intestinal disease in New Zealand.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3310455

Guillain--Barré syndrome and Campylobacter jejuni infection.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3310455

Incidence of Guillain-Barré syndrome following infection with Campylobacter jejuni

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3310455

Campylobacter species and Guillain-Barré syndrome

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3310455

H1N1 vaccine safety monitoring: beyond background rates

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3310455

Risk ranking for foodborne microbial hazards in New Zealand: burden of disease estimates.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3310455

Regulation of chicken contamination is urgently needed to control New Zealand's serious campylobacteriosis epidemic

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3310455

Guillain-Barré syndrome: a prospective, population-based incidence and outcome survey.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3310455

Preceding infections, immune factors, and outcome in Guillain-Barré syndrome

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3310455

Mild forms of Guillain-Barré syndrome in an epidemiologic survey in The Netherlands

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3310455

Guillain-Barré syndrome after use of alemtuzumab (Campath) in a patient with T-cell prolymphocytic leukemia: a case report and review of the literature

16 August 2018

1 reference

12 December 2020

Keep the focus on contaminated poultry to further curtail New Zealand's campylobacteriosis epidemic

1 reference

12 December 2020

Incidence of Guillain-Barré syndrome in Sweden 1996

1 reference

12 December 2020

Long-term impact on work and private life after Guillain-Barré syndrome

1 reference

12 December 2020

Identifiers

DOI

10.3201/EID1802.111126

1 reference

2 November 2017

1 reference

2 November 2017

PubMed publication ID

22304786

1 reference